npj Breast Cancer (Jul 2023)
Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial
- Yang Yang,
- Yingjian He,
- Zhaoqing Fan,
- Xue Chen,
- Yiqiang Liu,
- Chao Zhang,
- Hongchuan Jiang,
- Xin Wang,
- Xiang Wang,
- Fei Xie,
- Shu Wang,
- Bin Luo,
- Hua Kang,
- Tao Wang,
- Zefei Jiang,
- Peng Yuan,
- Binhe Xu,
- Ling Xu,
- Yinhua Liu,
- Jinfeng Li,
- Yuntao Xie,
- Tianfeng Wang,
- Tao Ouyang
Affiliations
- Yang Yang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Yingjian He
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Zhaoqing Fan
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Xue Chen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Yiqiang Liu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Chao Zhang
- Beijing Chao Yang Hospital, Breast Disease Department
- Hongchuan Jiang
- Beijing Chao Yang Hospital, Breast Disease Department
- Xin Wang
- Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department
- Xiang Wang
- Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department
- Fei Xie
- Peking University People’s Hospital, Breast Cancer Center
- Shu Wang
- Peking University People’s Hospital, Breast Cancer Center
- Bin Luo
- Beijing Tsinghua Changgeng Hospital, Breast Disease Department
- Hua Kang
- Xuan Wu Hospital Capital Medical University, Breast Disease Department
- Tao Wang
- 307 Hospital of PLA, Breast Cancer Department
- Zefei Jiang
- 307 Hospital of PLA, Breast Cancer Department
- Peng Yuan
- Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department
- Binhe Xu
- Cancer Hospital, Chinese Academy of Medical Sciences, Breast Cancer Department
- Ling Xu
- Peking University First Hospital, Breast Cancer Center
- Yinhua Liu
- Peking University First Hospital, Breast Cancer Center
- Jinfeng Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Yuntao Xie
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Tianfeng Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- Tao Ouyang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Center, Peking University Cancer Hospital & Institute
- DOI
- https://doi.org/10.1038/s41523-023-00567-6
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 1 – 1
Abstract
No abstracts available.